Zimmer Anticipates Lower-Than-Expected Pricing Cuts In Japan
This article was originally published in The Gray Sheet
Executive Summary
Zimmer predicts that upcoming Japanese pricing cuts will be less severe than expected, echoing a similar forecast by Stryker
You may also be interested in...
Stryker Plans To Quell Japanese Pricing Cut Storm With R&D Investments
Stryker will rely on developing its product pipeline in 2006 to withstand large price cuts from Japan in 2007, according to CEO Steve MacMillan
Chilly Japanese Medical Device Climate Draws Fire From Hill, Industry
Japan's regulatory and reimbursement systems came under fire this week from lawmakers on Capitol Hill and attendees of AdvaMed's international conference in Arlington, Va
Amneal Eyes Avastin And Praises $120m Biosimilar Development Savings
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: